Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone-Reference-Cited by-同舟云学术

Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone

Published:2019-09 Issue: Volume:310 Page:108742
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Adeyanju Oluwaseun A.,Falodun Timothy O.,Fabunmi Oyesanmi A.,Olatunji Lawrence A.,Soladoye Ayodele O.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference78 articles.

1. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?;van Houten;Reprod. Biol.,2014

2. The effects of exercise on expression of CYP19 and StAR mRNA in steroid induced polycystic ovaries of female rats;Aghaie;Int J Fertil Steril,2018

3. The genetics of the polycystic ovary syndrome;Urbanek;Nat. Clin. Pract. Endocrinol. Metabol.,2007

4. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy;Yao;Exp Ther Med,2017

5. Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome;Alphan;Med. Princ. Pract.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole‐induced polycystic ovary syndrome SD rats;Food Science & Nutrition;2024-01-24

2. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis;Frontiers in Endocrinology;2023-08-10

3. Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome;Toxicology and Applied Pharmacology;2023-08

4. Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats;Nutrire;2023-04-05

5. Blockade of mineralocorticoid receptor by low-dose spironolactone rescues hypothalamic-ovarian dysfunction in PCOS experimental rat model;Endocrine and Metabolic Science;2022-12